Australian based multiple myeloma authority Professor Joshua Douglas currently heads up Clinical and Laboratory Haematology at the Sydney Cancer Centre and is a former Director of the Institute of Haematology at Royal Prince Alfred Hospital.
He also chairs the Blood Clinical and Scientific Advisory Committee (BCSAC) of the NSW Department of Health and the National ARCBS ethics committee.
Professor Douglas is scientific advisor and member of the International Myeloma Foundation, the Multiple Myeloma Research Foundation, and is secretary of the International Myeloma Society. He serves on the editorial board of numerous journals.
Professor Douglas’s background in multiple myeloma will be invaluable to the company as it pushes forward with development of GGTI-2418 in this aggressive form of bone cancer.